跳至主要内容
临床试验/NCT07209722
NCT07209722已完成不适用

PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 1,377 人开始时间: 2023年9月22日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,377
试验地点
1
主要终点
PrEP Prescriptions

研究概览

简要总结

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient of UAB GYN clinic

排除标准

  • Not a patient of UAB GYN clinic

研究组 & 干预措施

Sexual Health-PRO

Patients seen during routine GYN clinic visit.

干预措施: PrEP acronym (pre-exposure prophylaxis) (Behavioral)

Post visit (fidelity) survey

Patients who completed the survey outside of clinic visit

干预措施: PrEP acronym (pre-exposure prophylaxis) (Behavioral)

结局指标

主要结局

PrEP Prescriptions

时间窗: 8 months

Number of participants receiving a new PrEP prescription during the recruitment period

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael J Mugavero, MD

Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验